Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
743 results:

  • 1. Circ_0087851 suppresses colorectal cancer malignant progression through triggering miR-593-3p/BAP1-mediated ferroptosis.
    Huang M; Gao T; Chen X; Yi J; Zhou X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):204. PubMed ID: 38642144
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
    Gan DEH; Bustam AZ
    J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perioperative and long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision: a retrospective study of 672 patients.
    Shadmanov N; Aliyev V; Piozzi GN; Bakır B; Goksel S; Asoglu O
    J Robot Surg; 2024 Mar; 18(1):144. PubMed ID: 38554211
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Association of Metabolic Risk Factors with Advanced Adenomas in Hispanic Patients.
    Tamai R; Dawit L; Lee P; Simmons OL; Ding L; Yuan L
    Dig Dis Sci; 2024 Apr; 69(4):1403-1410. PubMed ID: 38363522
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
    Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
    JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nine dietary habits and risk of colorectal cancer: a Mendelian randomization study.
    He M; Huan L; Wang X; Fan Y; Huang J
    BMC Med Genomics; 2024 Jan; 17(1):21. PubMed ID: 38233852
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inherited brca1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
    Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Establishment and Validation of a Postoperative VTE Prediction Model in Patients with colorectal cancer Undergoing Radical Resection: CRSPOT Nomogram.
    Wu Y; Wang L; Yin Q; Deng L; Ma J; Tian X
    Clin Appl Thromb Hemost; 2023; 29():10760296231216966. PubMed ID: 37997283
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers.
    Liu R; Qiu Z; Zhang L; Ma W; Zi L; Wang K; Kuang T; Zhao K; Wang W
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2509-2519. PubMed ID: 37990969
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
    Stålhammar G
    JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Short-Stay Left Colectomy for Colon cancer: Is It Safe?
    Papanikolaou A; Chen SY; Radomski SN; Stem M; Brown LB; Obias VJ; Graham AE; Chung H
    J Am Coll Surg; 2024 Feb; 238(2):172-181. PubMed ID: 37937826
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy of olaparib in advanced cancers with germline or somatic mutations in brca1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study.
    Joris S; Denys H; Collignon J; Rasschaert M; T'Kint de Roodenbeke D; Duhoux FP; Canon JL; Tejpar S; Mebis J; Decoster L; Aftimos P; De Grève J
    ESMO Open; 2023 Dec; 8(6):102041. PubMed ID: 37852034
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
    Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
    Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Deleterious and ethnic-related brca1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.
    Youssef ASE; Zekri ARN; Mohanad M; Loutfy SA; Abdel Fattah NF; Elberry MH; El Leithy AA; El-Touny A; Rabie AS; Shalaby M; Hanafy A; Lotfy MM; El-Sisi ER; El-Sayyad GS; Nassar A
    Clin Exp Med; 2023 Dec; 23(8):5063-5088. PubMed ID: 37804357
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Three cases of colon cancer in four generations of the Saudi family, caused by endogamous germline mutations.
    Alshaya DS; Al-Hazani TMI; Alotaibi MA; Domiaty DM; Alshehri E; Abdulla Alwaili M; Alotaibi AM; Jalal AS; AlQahtani AA; AlQassim FA; Albasher G; Saeed Al-Qahtani W
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):163-171. PubMed ID: 37715401
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.
    Wang T; Liu W; Shen Q; Tao R; Li C; Shen Q; Lin Y; Huang Y; Yang L; Xie G; Bai J; Li R; Wang L; Tao K; Yin Y
    Cancer Sci; 2023 Nov; 114(11):4184-4201. PubMed ID: 37702298
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Report on the Effect of the Implementation of an Early Detection and Prevention of cancer Program on Families at High Hereditary Risk-Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland.
    Kałużewski T; Kubiak I; Bednarek M; Sałamunia J; Kucharska D; Kępczyński Ł; Stempień M; Kubicki T; Trzciński R; Gordon-Sönmez Z; Bartosińska-Dyc A; Gach A; Kałużewski B
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685988
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis.
    Feng Z; Yang X; Tian M; Zeng N; Bai Z; Deng W; Zhao Y; Guo J; Yang Y; Zhang Z; Yang Y
    BMC Cancer; 2023 Aug; 23(1):807. PubMed ID: 37644384
    [TBL] [Abstract] [Full Text] [Related]  


    of 38.